Success Story: Two Approvals, One Journey: Iranian Postdoc Earns NIW & EB1A – EB1A in Just 11 Days!

Client’s Testimonial:

“Thank you very much for your outstanding support throughout this journey.”

On October 2^nd, 2024, and June 13^th, 2025, we received another EB-2 NIW (National Interest Waiver) and EB-1A (Alien of Extraordinary Ability) approvals for a Postdoctoral Associate in the Field of Diagnostic Biomarkers (Approval Notice).

General Field: Diagnostic Biomarkers

Position at the Time of Case Filing: Postdoctoral Associate

Country of Origin: Iran

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: : October 2^nd, 2024 (NIW); June 13^th, 2025 (EB1A)

Processing Time: 9 months, 19 days (NIW), and 11 days (EB1A – Premium Processing Requested)

Case Summary:

We are thrilled to announce the approval of both the National Interest Waiver (NIW) and EB1A I-140 petitions for a highly accomplished medical researcher specializing in diagnostic biomarkers. The NIW petition was approved in October 2024, followed by EB1A approval under premium processing in June 2025. These decisions reflect the extraordinary impact of the petitioner’s contributions to neuropsychiatry, cancer research, radiology, and pain diagnostics.

Innovating at the Intersection of Medicine, Imaging, and AI

With an M.D. and extensive clinical research experience, the petitioner is recognized as one of the few leading specialists in the diagnostic biomarkers field. He is particularly known for leveraging neuroimaging, nanotechnology, and artificial intelligence to develop precise diagnostic and therapeutic tools for neuropsychiatric disorders, cancer, chronic pain, and COVID-19 complications.

Currently conducting translational research in a prominent U.S. medical setting, the petitioner’s ongoing projects include the integration of high-field MRI, brain stimulation technologies, and radiomic modeling, paving the way for more personalized and predictive healthcare.

A Substantial Record of Scientific Impact

At the time of filing, the petitioner had authored:

33 peer-reviewed journal articles,
7 preprints,
2 published and 1 accepted book chapters,
3 abstracts.

His publications had been cited 376 times, with at least 7 articles ranking in the top 1–10% most cited in clinical medicine for their year. In addition, he has completed 30+ peer reviews for top journals and serves on editorial boards for multiple international publications in neuroscience and imaging.

International Expert Support and Recognition

The petition was accompanied by seven letters of recommendation, including five from independent recommenders affiliated with leading academic and clinical institutions across the U.S. and Europe. These letters emphasized the originality, relevance, and global applicability of the petitioner’s work.

“It is extremely noteworthy that [Client] has been asked to perform these duties on multiple occasions, and this positively confirms his elevated standing in the field of diagnostic biomarkers.”

Transforming U.S. Public Health and Scientific Leadership

Through highly cited research and practical innovations in AI-driven diagnostics, neuromodulation, and pain management, the petitioner’s work contributes directly to national priorities in healthcare, precision medicine, and pandemic response. His approvals under both NIW and EB1A underscore the lasting value of his expertise to U.S. scientific advancement.

We are honored to support such an impactful researcher and look forward to his continued success.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.